Interleukin-2

The Cytokine Handbook

Volumn , Issue , 2003, Pages 167-199

  Lin, Jian Xin ^a   Leonard, Warren J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84942877339     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012689663-3/50012-0     Document Type: Chapter

References (373)

1. Abraham R.T., Wiederrecht G.J. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 1996, 14:483-510.
2. Ahmed N.N., Grimes H.L., Bellacosa A., et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc/Natl/Acad/Sci/USA 1997, 94:3627-3632.
3. Aman M.J., Migone T.S., Sasaki A., et al. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling. J. Biol. Chem. 1999, 274:30266-30272.
4. Arima N., Kuziel W.A., Grdina T.A., Greene W.C. IL-2-induced signal transduction involves the activation of nuclear NF-kappa B expression. J. Immunol. 1992, 149:83-91.
5. Asao H.aiTakeshita^T., Nakamura M., et al. Interleukin 2 (IL-2)-induced tyrosine phosphorylation of IL-2 receptor p75. J. Exp. Med. 1990, 171:637-644.
6. Asao H., Kumaki S., Takeshita T., et al. IL-2-dependent in vivo and in vitro tyrosine phosphorylation of IL-2 receptor gamma chain. FEBS Lett. 1992, 304:141-145.
7. Asao H., Takeshita T., Ishii N., et al. Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the gamma chain in two distinct signaling pathways. Proc. Natl Acad. Sci. USA 1993, 90:4127-4131.
8. Asao H., Okuyama C., Kumaki S., et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL-21 receptor complex. J. Immunol. 2001, 167:1-5.
9. Ascherman D.P., Migone T.S., Friedmann M.C., Leonard W.J. Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation. J. Biol. Chem. 1997, 272:8704-8709.
10. Atkins M.B., Lotze M.T., Dutcher J.P., et al. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol. 1999, 17:2105-2116.
11. Augustine J.A., Schlager J.W., Abraham R.T. Differential effects of interleukin-2 and interleukin-4 on protein tyrosine phosphorylation in factor-dependent murine T cells. Biochim. Biophys. Acta 1990, 1052:313-322.
12. Augustine J.A., Sutor S.L., Abraham R.T. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol. Cell. Biol. 1991, 11:4431-4440.
13. Bach E.A., Aguet M., Schreiber R.D. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 1997, 15:563-591.
14. Ballard D.W., Bohnlein E., Hoffman J.A., et al. Activation of the interleukin-2 receptor alpha gene: regulatory role for DNA-protein interactions flanking the kappa B enhancer. New Biol. 1989, 1:83-92.
15. Bamford R.N., Grant A.J., Burton J.D., et al. The interleukin (IL) 2 receptor beta chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994, 91:4940-4944.
16. Barber E.K., Dasgupta J.D., Schlossman S.F., et al. The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex. Proc. Natl Acad. Sci. USA 1989, 86:3277-3281.
17. Bazan J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA 1990, 87:6934-6938.
18. Bazan J.F. Unraveling the structure of IL-2. Science 1992, 257:410-443.
19. Beadling C., Johnson K.W., Smith K.A. Isolation of interleukin 2-induced immediate-early genes. Proc. Natl Acad. Sci. USA 1993, 90:2719-2723.
20. Blackman M.A., Tigges M.A., Minie M.E., Koshland M.E. A model system for peptide hormone action in differentiation: interleukin 2 induces a B lymphoma to transcribe the J chain gene. Cell 1986, 47:609-617.
21. Bohnlein E., Lowenthal J.W., Siekevitz M., et al. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 1988, 53:827-836.
22. Bolen J.B., Thompson P.A., Eiseman E., Horak I.D. Expression and interactions of the Src family of tyrosine protein kinases in T lymphocytes. Adv. Cancer Res. 1991, 57:103-149.
23. Bosco M.C., Espinoza-Delgado I., Schwabe M., et al. The gamma subunit of the interleukin-2 receptor is expressed in human monocytes and modulated by interleukin-2, interferon gamma, and transforming growth factor beta 1. Blood 1994, 83:3462-3467.
24. Boussiotis V.A., Barber D.L., Nakarai T., et al. Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor. Science 1994, 266:1039-1042.
25. Bram R.J., Hung D.T., Martin P.K., et al. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell Biol. 1993, 13:4760-4769.
26. Brandhuber B.J., Boone T., Kenney W.C., McKay D.B. Crystals and a low resolution structure of interleukin-2. J. Biol. Chem. 1987, 262:12306-12308.
27. Brandhuber B.J., Boone T., Kenney W.C., McKay D.B. Three-dimensional structure of interleukin-2. Science 1987, 238:1707-1709.
28. Brennan P., Babbage J.W., Burgering B.M., et al. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 1997, 7:679-689.
29. Broome H.E., Dargan C.M., Krajewski S., Reed J.C. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J. Immunol. 1995, 155:2311-2317.
30. Brorson K.A., Beverly B., Kang S.M., et al. Transcriptional regulation of cytokine genes in nontransformed T cells. Apparent constitutive signals in run-on assays can be caused by repeat sequences. J. Immunol. 1991, 147:3601-3609.
31. Brown T.J., Rowe J.M., Liu J.W., Shoyab M. Regulation of IL-6 expression by oncostatin M. J. Immunol. 1991, 147:2175-2180.
32. Burns L.A., Karnitz L.M., Sutor S.L., Abraham R.T. Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes. J. Biol. Chem. 1993, 268:17659-17661.
33. Burton J.D., Bamford R.N., Peters C., et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl Acad. Sci. USA 1994, 91:4935-4939.
34. Calvo V., Crews C.M., Vik T.A., Bierer B.E. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl Acad. Sci. USA 1992, 89:7571-7575.
35. Cambier J.C., Pleiman C.M., Clark M.R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 1994, 12:457-486.
36. Cantrell D. T cell antigen receptor signal transduction pathways. Annu. Rev. Immunol. 1996, 14:259-274.
37. Cao X., Kozak C.A., Liu Y.J., et al. Characterization of cDNAs encoding the murine interleukin 2 receptor (IL-2R) gamma chain: chromosomal mapping and tissue specificity of IL-2R gamma chain expression. Proc. Natl Acad. Sci. USA 1993, 90:8464-8468.
38. Cao X., Shores E.W., Hu-Li J., et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995, 2:223-238.
39. Carpenter C.L., Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell. Biol. 1996, 8:153-158.
40. Carson W.E., Giri J.G., Lindemann M.J., et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994, 180:1395-1403.
41. Casey L.S., Lichtman A.H., Boothby M. IL-4 induces IL-2 receptor p75 beta-chain gene expression and IL-2-dependent proliferation in mouse T lymphocytes. J. Immunol. 1992, 148:3418-3426.
42. Castigli E., Pahwa R., Good R.A., et al. Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency. Proc. Natl Acad. Sci. USA 1993, 90:4728-4732.
43. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., et al. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells. Blood 1996, 88:3901-3909.
44. Cavazzana-Calvo M., Hacein-Bey S., de Saint Basile G., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000, 288:669-672.
45. Cerdan C., Martin Y., Courcoul M., et al. CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. J. Immunol. 1995, 154:1007-1013.
46. Cerretti D.P., McKereghan K., Larsen A., et al. Cloning, sequence, and expression of bovine interleukin 2. Proc. Natl Acad. Sci. USA 1986, 83:3223-3227.
47. Chan A.C., Irving B.A., Weiss A. New insights into T-cell antigen receptor structure and signal transduction. Curr. Opin. Immunol. 1992, 4:246-251.
48. Chatila T., Castigli E., Pahwa R., et al. Primary combined immunodeficiency resulting from defective transcription of multiple T-cell lymphokine genes. Proc. Natl Acad. Sci. USA 1990, 87:10033-10037.
49. Chen S.J., Holbrook N.J., Mitchell K.F., et al. A viral long terminal repeat in the interleukin 2 gene of a cell line that constitutively produces interleukin 2. Proc. Natl Acad. Sci. USA 1985, 82:7284-7288.
50. Cheng A.M., Rowley B., Pao W., et al. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 1995, 378:303-306.
51. Chida D., Wakao H., Yoshimura A., Miyajima A. Transcriptional regulation of the beta-casein gene by cytokines: cross-talk between STAT5 and other signaling molecules. Mol. Endocrinol. 1998, 12:1792-1806.
52. Cipres A., Carrasco S., Merida I. Deletion of the acidic-rich domain of the IL-2Rbeta chain increases receptor-associated PI3K activity. FEBS Lett 2001, 500:99-104.
53. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992, 357:695-697.
54. Cohen G.B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell 1995, 80:237-248.
55. Cohney S.J., Sanden D., Cacalano N.A., et al. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 1999, 19:4980-4988.
56. Collins L., Tsien W.H., Seals C., et al. Identification of specific residues of human interleukin 2 that affect binding to the 70-kDa subunit (p70) of the interleukin 2 receptor. Proc. Natl Acad. Sci. USA 1988, 85:7709-7713.
57. Cosman D., Cerretti D.P., Larsen A., et al. Cloning, sequence and expression of human interleukin-2 receptor. Nature 1984, 312:768-771.
58. Critchfield J.M., Racke M.K., Zuniga-Pflucker J.C., et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 1994, 263:1139-1143.
59. Cross S.L., Halden N.F., Lenardo M.J., Leonard W.J. Functionally distinct NF-kappa B binding sites in the immunoglobulin kappa and IL-2 receptor alpha chain genes. Science 1989, 244:466.
60. Cutler R.L., Liu L., Damen J.E., Krystal G. Multiple cytokines induce the tyrosine phosphorylation of Shc and its association with Grb2 in hemopoietic cells. J. Biol. Chem. 1993, 268:21463-21465.
61. Danial N.N., Pernis A., Rothman P.B. Jak-STAT signaling induced by the v-abl oncogene. Science 1995, 269:1875-1877.
62. David D., Bani L., Moreau J.L., et al. Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc. Natl Acad. Sci. USA 1998, 95:11348-11353.
63. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem. Sci. 1994, 19:470-473.
64. Degrave W., Simons G., Devos R., et al. Cloning and structure of a mouse interleukin-2 chromosomal gene. Mol. Biol. rep. 1986, 11:57-61.
65. Demoulin J.B., Uyttenhove C., Van R.E., et al. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol. Cell. Biol. 1996, 16:4710-4716.
66. de Saint Basile G., Arveiler B., Oberle I., et al. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13. Proc. Natl Acad. Sci. USA 1987, 84:7576-7579.
67. de Vos A.M., Ultsch M., Kossiakoff A.A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992, 255:306-312.
68. Devos R., Plaetinck G., Cheroutre H., et al. Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res. 1983, 11:4307-4323.
69. DiSanto J.P., Muller W., Guy-Grand D., et al. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc. Natl Acad. Sci. USA 1995, 92:377-381.
70. Djeu J.Y., Liu J.H., Wei S., et al. Function associated with IL-2 receptor-beta on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J. Immunol. 1993, 150:960-970.
71. Domzig W., Stadler B.M., Herberman R.B. Interleukin 2 dependence of human natural killer (NK) cell activity. J. Immunol. 1983, 130:1970-1973.
72. Dukovich M., Wano Y., Thuy L.T.B., et al. A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature 1987, 327:518-522.
73. Duronio V., Welham M.J., Abraham S., et al. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc. Natl Acad. Sci. USA 1992, 89:1587-1591.
74. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 1998, 12:2245-2262.
75. Endo K., Takeshita T., Kasai H., et al. STAM2, a new member of the STAM family, binding to the Janus kinases. FEBS Lett. 2000, 477:55-61.
76. Epling-Burnette P.K., Wei S., Blanchard D.K., et al. Coinduction of granulocyte-macrophage colony-stimulating factor release and lymphokine-activated killer cell susceptibility in monocytes by interleukin-2 via interleukin-2 receptor beta. Blood 1993, 81:3130-3137.
77. Espinoza-Delgado I., Ortaldo J.R., Winkler-Pickett R., et al. Expression and role of p75 interleukin 2 receptor on human monocytes. J. Exp. Med. 1990, 171:1821-1826.
78. Farrar W.L., Ferris D.K., Harel-Bellan A. The molecular basis of immune cytokine action. Crit. Rev. Ther. Drug Carrier Syst. 1989, 5:229-261.
79. Fernandez-Botran R., Chilton P.M., Ma Y. Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv. Immunol. 1996, 63:269-336.
80. Fischer A., Hacein-Bey S., Le D.F., et al. Gene therapy for human severe combined immunodeficiencies. Immunity 2001, 15:1-4.
81. Flanagan W.M., Corthesy B., Bram R.J., Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 1991, 352:803-807.
82. Franke T.F., Kaplan D.R., Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 1997, 88:435-437.
83. Fraser J.D., Irving B.A., Crabtree G.R., Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991, 251:313-316.
84. Fraser J.D., Newton M.E., Weiss A. CD28 and T cell antigen receptor signal transduction coordinately regulate interleukin 2 gene expression in response to superantigen stimulation. J. Exp. Med. 1992, 175:1131-1134.
85. Friedmann M.C., Migone T.S., Russell S.M., Leonard W.J. Different interleukin 2 receptor beta-chain tyrosines couple to at least two signaling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl Acad. Sci. USA 1996, 93:2077-2082.
86. Fujii H., Nakagawa Y., Schindler U., et al. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission. Proc. Natl Acad. Sci. USA 1995, 92:5482-5486.
87. Fujii H., Ogasawara K., Otsuka H., et al. Functional dissection of the cytoplasmic subregions of the IL-2 receptor betac chain in primary lymphocyte populations. EMBO J. 1998, 17:6551-6557.
88. Fujita T., Takaoka C., Matsui H., Taniguchi T. Structure of the human interleukin 2 gene. Proc. Natl Acad. Sci. USA 1983, 80:7437-7441.
89. Fukunaga R., Ishizaka-Ikeda E., Pan C.X., et al. Functional domains of the granulocyte colony-stimulating factor receptor. EMBO J. 1991, 10:2855-2865.
90. Fuse A., Fujita T., Yasumitsu H., et al. Organization and structure of the mouse interleukin-2 gene. Nucleic Acids Res. 1984, 12:9323-9331.
91. Fyfe G., Fisher R.I., Rosenberg S.A., et al. Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J. Clin. Oncol. 1995, 13:688-696.
92. Gadina M., Stancato L.M., Bacon C.M., et al. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. J. Immunol. 1998, 160:4657-4661.
93. Gadina M., Sudarshan C., O'Shea J.J. IL-2, but not IL-4 and other cytokines, induces phosphorylation of a 98-kDa protein associated with SHP-2, phosphatidylinositol 3'-kinase, and Grb2. J. Immunol. 1999, 162:2081-2086.
94. Gaffen S.L., Wang S., Koshland M.E. Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin 2. Cytokine 1996, 8:513-524.
95. Garrity P.A., Chen D., Rothenberg E.V., Wold B.J. Interleukin-2 transcription is regulated in vivo at the level of coordinated binding of both constitutive and regulated factors. Mol. Cell. Biol. 1994, 14:2159-2169.
96. Gesbert F., Guenzi C., Bertoglio J. A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes. J. Biol. Chem. 1998, 273:18273-18281.
97. Gillis S., Smith K.A., Watson J. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J. Immunol. 1980, 124:1954-1962.
98. Gilmour K.C., Fujii H., Cranston T., et al. Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. Blood 2001, 98:877-879.
99. Giri J.G., Ahdieh M., Eisenman J., et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994, 13:2822-2830.
100. Giri J.G., Kumaki S., Ahdieh M., et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995, 14:3654-3663.
101. Gnarra J.R., Otani H., Wang M.G., et al. Human interleukin 2 receptor beta-chain gene: chromosomal localization and identification of 5' regulatory sequences. Proc. Natl Acad. Sci. USA 1990, 87:3440-3444.
102. Goldsmith M.A., Lai S.Y., Xu W., et al. Growth signal transduction by the human interleukin-2 receptor requires cytoplasmic tyrosines of the beta chain and nontyrosine residues of the gamma c chain. J. Biol. Chem. 1995, 270:21729-21737.
103. Goodall J.C., Emery D.C., Bailey M., et al. cDNA cloning of porcine interleukin 2 by polymerase chain reaction. Biochim. Biophys. Acta 1991, 1089:257-258.
104. Grabstein K.H., Eisenman J., Shanebeck K., et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994, 264:965-968.
105. Grant A.J., Roessler E., Ju G., et al. The interleukin 2 receptor (IL-2R): the IL-2R alpha subunit alters the function of the IL-2R beta subunit to enhance IL-2 binding and signaling by mechanisms that do not require binding of IL-2 to IL-2R alpha subunit. Proc. Natl Acad. Sci. USA 1992, 89:2165-2169.
106. Granucci F., Vizzardelli C., Pavelka N., et al. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2001, 2:882-888.
107. Gratiot-Deans J., Merino R., Nunez G., Turka L.A. Bcl-2 expression during T-cell development: early loss and late return occur at specific stages of commitment to differentiation and survival. Proc. Natl Acad. Sci. USA 1994, 91:10685-10689.
108. Greene W.C., Robb R.J., Svetlik P.B., et al. Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells. J. Exp. Med. 1985, 162:363-368.
109. Grimm E.A., Rayner A.A., Wilson D.J. Human NK resistant tumor cell lysis is effected by IL-2 activated killer cells. Adv. Exp. Med. Biol. 1985, 184:161-175.
110. Gu H., Pratt J.C., Burakoff S.J., Neel B.G. Cloning of p97/Gab2, the major SHP2-binding protein in hematopoietic cells, reveals a novel pathway for cytokine-induced gene activation. Mol. Cell. 1998, 2:729-740.
111. Guex-Crosier Y., Raber J., Chan C.C., et al. Humanized antibodies against the alpha-chain of the IL-2 receptor and against the beta-chain shared by the IL-2 and IL-15 receptors in a monkey uveitis model of autoimmune diseases. J. Immunol. 1997, 158:452-458.
112. Hakimi J., Ha V.C., Lin P., et al. Humanized Mik beta 1, a humanized antibody to the IL-2 receptor beta-chain that acts synergistically with humanized anti-TAC. J. Immunol. 1993, 151:1075-1085.
113. Harel-Bellan A., Bertoglio J., Quillet A., et al. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. J. Immunol. 1986, 136:2463-2469.
114. Hatakeyama M., Tsudo M., Minamoto S., et al. Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNAs. Science 1989, 244:551-556.
115. Hatakeyama M., Mori H., Doi T., Taniguchi T. A restricted cytoplasmic region of IL-2 receptor beta chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 1989, 59:837-845.
116. Hatakeyama M., Kono T., Kobayashi N., et al. Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association. Science 1991, 252:1523-1558.
117. Hatakeyama M., Kawahara A., Mori H., et al. c-fos gene induction by interleukin 2: identification of the critical cytoplasmic regions within the interleukin 2 receptor beta chain. Proc. Natl Acad. Sci. USA 1992, 89:2022-2026.
118. Helin K. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 1998, 8:28-35.
119. Horak I.D., Gress R.E., Lucas P.J., et al. T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc. Natl Acad. Sci. USA 1991, 88:1996-2000.
120. Horvath C.M., Darnell J.E. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell. Biol. 1997, 9:233-239.
121. Hou J., Schindler U., Henzel W.J., et al. Identification and purification of human Stat proteins activated in response to interleukin-2. Immunity 1995, 2:321-339.
122. Imada K., Bloom E.T., Nakajima H., et al. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J. Exp. Med. 1998, 188:2067-2074.
123. Ishida N., Kanamori H., Noma T., et al. Molecular cloning and structure of the human interleukin 2 receptor gene. Nucleic Acids Res. 1985, 13:7579-7589.
124. Jain J., Loh C., Rao A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 1995, 7:333-342.
125. John S., Reeves R.B., Lin J.X., et al. Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins. Mol. Cell. Biol. 1995, 15:1786-1796.
126. John S., Robbins C.M., Leonard W.J. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5, Elf-1, HMG-I(Y) and a GATA family protein. EMBO J. 1996, 15:5627-5635.
127. John S., Vinkemeier U., Soldaini E., et al. The significance of tetramerization in promoter recruitment by Stat5. Mol. Cell. Biol. 1999, 19:1910-1918.
128. Johnston J.A., Kawamura M., Kirken R.A., et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994, 370:151-153.
129. Ju G., Collins L., Kaffka K.L., et al. Structure-function analysis of human interleukin-2. Identification of amino acid residues required for biological activity. J. Biol. Chem. 1987, 262:5723-5731.
130. June C.H., Ledbetter J.A., Lindsten T., Thompson C.B. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. J. Immunol. 1989, 143:153-161.
131. Karnitz L., Sutor S.L., Torigoe T., et al. Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line. Mol. Cell. Biol. 1992, 12:4521-4530.
132. Karnitz L.M., Sutor S.L., Abraham R.T. The Src-family kinase, Fyn, regulates the activation of phosphatidylinositol 3-kinase in an interleukin 2-responsive T cell line. J. Exp. Med. 1994, 179:1799-1808.
133. Karnitz L.M., Burns L.A., Sutor S.L., et al. Interleukin-2 triggers a novel phosphatidylinositol 3-kinase-dependent MEK activation pathway. Mol. Cell. Biol. 1995, 15:3049-3057.
134. Kashima N., Nishi-Takaoka C., Fujita T., et al. Unique structure of murine interleukin-2 as deduced from cloned cDNAs. Nature 1985, 313:402-444.
135. Kawahara A., Minami Y., Taniguchi T. Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4, and IL-7 signalling. Mol. Cell. Biol. 1994, 14:5433-5440.
136. Kawahara A., Minami Y., Miyazaki T., et al. Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl Acad. Sci. USA 1995, 92:8724-8778.
137. Kennedy M.K., Glaccum M., Brown S.N., et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 2000, 191:771-780.
138. Kiani A., Rao A., Aramburu J. Manipulating immune responses with immunosuppressive agents that target NFAT. Immunity 2000, 12:359-372.
139. Kim H.P., Kelly J., Leonard W.J. The basis for IL-2-induced IL-2 receptor alpha chain gene regulation: importance of two widely separated IL-2 response elements. Immunity 2001, 15:159-172.
140. Kim H.P., Leonard W.J. The basis for TCR-mediated regulation of the IL-2 receptor alpha chain gene: role of widely separated regulatory elements. EMBO J. 2002, 17:3051-3059.
141. Kimura Y., Takeshita T., Kondo M., et al. Sharing of the IL-2 receptor gamma chain with the functional IL-9 receptor complex. Int. Immunol. 1995, 7:115-120.
142. Kobayashi N., Kono T., Hatakeyama M., et al. Functional coupling of the src-family protein tyrosine kinases p59fyn and p53/56lyn with the interleukin 2 receptor: implications for redundancy and pleiotropism in cytokine signal transduction. Proc. Natl Acad. Sci. USA 1993, 90:4201-4225.
143. Kondo M., Takeshita T., Ishii N., et al. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 1993, 262:1874-1887.
144. Kondo M., Takeshita T., Higuchi M., et al. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes. Science 1994, 263:1453-1454.
145. Koradi R., Billeter M., Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 1996, 14:29-32.
146. Kovanen P.E., Leonard W.J. Inhibitors keep cytokines in check. Curr. Biol. 1999, 9:R899-R902.
147. Kovanen P.E., Rosenwald A., Fu J., et al. Analysis of γc-family cytokine target genes: identification of DUSP5 as a regulator of MAP kinase activity in IL-2 signaling. J. Biol. Chem. 2003, in press.
148. Kronke M., Leonard W.J., Depper J.M., Greene W.C. Sequential expression of genes involved in human T lymphocyte growth and differentiation. J. Exp. Med. 1985, 161:1593-1598.
149. Kumaki S., Asao H., Takeshita T., et al. Cell type-specific tyrosine phosphorylation of IL-2 receptor beta chain in response to IL-2. FEBS Lett. 1992, 310:22-26.
150. Kundig T.M., Schorle H., Bachmann M.F., et al. Immune responses in interleukin-2-deficient mice. Science 1993, 262:1059-1061.
151. Kuo L.M., Robb R.J. Structure-function relationships for the IL 2-receptor system. I. Localization of a receptor binding site on IL 2. J. Immunol. 1986, 137:1538-1543.
152. Kuo C.J., Chung J., Fiorentino D.F., et al. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992, 358:70-73.
153. Lanier L.L., Kipps T.J., Phillips J.H. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen). J. Exp. Med. 1985, 162:2089-2106.
154. Lansford R.D., McFadden H.J., Siu S.T., et al. A promoter element that exerts positive and negative control of the interleukin 2-responsive J-chain gene. Proc. Natl Acad. Sci. USA 1992, 89:5966-5970.
155. Law C.L., Sidorenko S.P., Chandran K.A., et al. Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J. Biol. Chem. 1994, 269:12310-12319.
156. Lecine P., Algarte M., Rameil P., et al. Elf-1 and Stat5 bind to a critical element in a new enhancer of the human interleukin-2 receptor alpha gene. Mol. Cell. Biol. 1996, 16:6829-6840.
157. Leclercq G., Debacker V., de Smedt M., Plum J. Differential effects of interleukin-15 and interleukin-2 on differentiation of bipotential T/natural killer progenitor cells. J. Exp. Med. 1996, 184:325-336.
158. Lenardo M.J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991, 353:858-861.
159. Lenardo M., Chan K.M., Hornung F., et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 1999, 17:221-253.
160. Leonard W.J. Type I cytokines and interferons and their receptors. Fundamental Immunology 1999, 741-774. Lippincott-Raven, Philadelphia. fourth edition. W.E. Paul (Ed.).
161. Leonard W.J. Cytokines and immunodeficiency diseases. Nature Rev: Immunol. 2001, 1:200-208.
162. Leonard W.J., O'Shea J.J. Jaks and STATs: biological implications. Annu. Rev. Immunol. 1998, 16:293-322.
163. Leonard W.J., Depper J.M., Uchiyama T., et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 1982, 300:267-269.
164. Leonard W.J., Depper J.M., Crabtree G.R., et al. Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 1984, 311:626-631.
165. Leonard W.J., Depper J.M., Kanehisa M., et al. Structure of the human interleukin-2 receptor gene. Science 1985, 230:633-639.
166. Leonard W.J., Kronke M., Peffer N.J., et al. Interleukin 2 receptor gene expression in normal human T lymphocytes. Proc. Natl Acad. Sci. USA 1985, 82:6281-6285.
167. Leonard W.J., Noguchi M., Russell S.M., McBride O.W. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c. Immunol. Rev. 1994, 138:61-86.
168. Leung K., Nabel G.J. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. Nature 1988, 333:776-778.
169. Lin J.X., Leonard W.J. Signaling from the IL-2 receptor to the nucleus. Cytokine Growth Factor Rev. 1997, 8:313-332.
170. Lin J.X., Leonard W.J. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol. Cell. Biol. 1997, 17:3714-3722.
171. Lin J.X., Bhat N.K., John S., et al. Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products. Mol. Cell. Biol. 1993, 13:6201-6210.
172. Lin J.X., Migone T.S., Tsang M., et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-15. Immunity 1995, 2:331-339.
173. Lin J.X., Mietz J., Modi W.S., et al. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells. J. Biol. Chem. 1996, 271:10738-10744.
174. Lindstein T., June C.H., Ledbetter J.A., et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989, 244:339-343.
175. Liu J.H., Wei S., Ussery D., et al. Expression of interleukin-2 receptor gamma chain on human neutrophils. Blood 1994, 84:3870-3885.
176. Liu X., Robinson G.W., Wagner K.U., et al. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997, 11:179-186.
177. Lo M., Bloom M.L., Imada K., et al. Restoration of lymphoid populations in a murine model of X-linked severe combined immunodeficiency by a gene-therapy approach. Blood 1999, 94:3027-3036.
178. Lodolce J.P., Boone D.L., Chai S., et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998, 9:669-676.
179. London L., Perussia B., Trinchieri G. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells. J. Immunol. 1986, 137:3845-3854.
180. Loughnan M.S., Nossal G.J. Interleukin 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains. Nature 1989, 340:76-79.
181. Lowenthal J.W., Greene W.C. Contrasting interleukin 2 binding properties of the alpha (p55) and beta (p70) protein subunits of the human high-affinity interleukin 2 receptor. J. Exp. Med. 1987, 166:1156-1161.
182. Ma A., Boone D.L., Lodolce J.P. The pleiotropic functions of interleukin 15: not so interleukin 2-like after all. J. Exp. Med. 2000, 191:753-756.
183. Macchi P., Villa A., Giliani S., et al. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 1995, 377:65-68.
184. Maeda M., Arima N., Daitoku Y., et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 1987, 70:1407-1411.
185. Malik N., Haugen H.S., Modrell B., et al. Developmental abnormalities in mice transgenic for bovine oncostatin M. Mol. Cell. Biol. 1995, 15:2349-2358.
186. Malkovsky M., Loveland B., North M., et al. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 1987, 325:262-625.
187. Marine J.C., McKay C., Wang D., et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell 1999, 98:617-627.
188. Marine J.C., Topham D.J., McKay C., et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999, 98:609-616.
189. Martin S.J., Green D.R. Protease activation during apoptosis: death by a thousand cuts?. Cell 1995, 82:349-352.
190. Matsumoto A., Seki Y., Kubo M., et al. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice. Mol. Cell. Biol. 1999, 19:6396-6407.
191. McFadden H.J., Koshland M.E. Interleukin 2-and interleukin 5-induced changes in the binding of regulatory factors to the J-chain gene promoter. Proc. Natl Acad. Sci. USA 1991, 88:11027-11031.
192. McKnight A.J., Mason D.W., Barclay A.N. Sequence of rat interleukin 2 and anomalous binding of a mouse interleukin 2 cDNA probe to rat MHC class II-associated invariant chain mRNA. Immunogenetics 1989, 30:145-147.
193. Merida I., Pratt J.C., Gaulton G.N. Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules. Proc. Natl Acad. Sci. USA 1990, 87:9421-9425.
194. Meerida I., Diez E., Gaulton G.N. IL-2 binding activatesatyrosine-phosphorylatedphosphatidylinositol-3-kinase. J. Immunol. 1991, 147:2202-2207.
195. Merida I., Williamson P., Kuziel W.A., et al. The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation. J. Biol. Chem. 1993, 268:6765-6770.
196. Migone T.S., Lin J.X., Cereseto A., et al. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 1995, 269:79-81.
197. Migone T.S., Rodig S., Cacalano N.A., et al. Functional cooperation of the interleukin-2 receptor beta chain and Jak1 in phosphatidylinositol 3-kinase recruitment and phosphorylation. Mol. Cell. Biol. 1998, 18:6416-6422.
198. Minami Y., Kono T., Yamada K., et al. Association of p56lck with IL-2 receptor beta chain is critical for the IL-2-induced activation of p56lck. EMBO J. 1993, 12:759-768.
199. Minami Y., Oishi I., Liu Z.J., et al. Signal transduction mediated by the reconstituted IL-2 receptor. Evidence for a cell type-specific function of IL-2 receptor beta-chain. J. Immunol. 1994, 152:5680-5690.
200. Minami Y., Nakagawa Y., Kawahara A., et al. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 1995, 2:89-100.
201. Minamoto S., Mori H., Hatakeyama M., et al. Characterization of the heterodimeric complex of human IL-2 receptor alpha. beta chains reconstituted in a mouse fibroblast cell line, L929. J. Immunol. 1990, 145:2177-2182.
202. Mingari M.C., Gerosa F., Carra G., et al. Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984, 312:641-643.
203. Miyazaki T., Kawahara A., Fujii H., et al. Functional activation of Jak1 and Jak3 by selective association with Il-2 receptor subunits. Science 1994, 266:1045-1047.
204. Miyazaki T., Liu Z.J., Kawahara A., et al. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 1995, 81:223-231.
205. Molina T.J., Kishihara K., Siderovski D.P., et al. Profound block in thymocyte development in mice lacking p56lck. Nature 1992, 357:161-164.
206. Monfar M., Lemon K.P., Grammer T.C., et al. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 1995, 15:326-337.
207. Morgan D.A., Ruscetti F.W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 1976, 193:1007-1008.
208. Moriggl R., Sexl V., Piekorz R., et al. Stat5 activation is uniquely associated with cytokine signaling in peripheral T cells. Immunity 1999, 11:225-230.
209. Moriggl R., Topham D.J., Teglund S., et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 1999, 10:249-259.
210. Morris J.C., Waldmann T.A. Advances in interleukin 2 receptor targeted treatment. Ann. Rheum. Dis. 2000, 59(Suppl. 1):109-114.
211. Murakami M., Narazaki M., Hibi M., et al. Critical cytoplasmic region of the interleukin 6 signal transducer gp 130 is conserved in the cytokine receptor family. Proc. Natl Acad. Sci. USA 1991, 88:11349-11353.
212. Musso T., Johnston J.A., Linnekin D., et al. Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J. Exp. Med. 1995, 181:1425-1431.
213. Myszka D.G., Arulanantham P.R., Sana T., et al. Kinetic analysis of ligand binding to interleukin-2 receptor complexes created on an optical biosensor surface. Protein Sci. 1996, 5:2468-2478.
214. Nakajima H., Liu X.W., Wynshaw-Boris A., et al. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity 1997, 7:691-701.
215. Nakajima H., Shores E.W., Noguchi M., Leonard W.J. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J. Exp. Med. 1997, 185:189-195.
216. Nakamura Y., Russell S.M., Mess S.A., et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994, 369:330-333.
217. Nakanishi K., Malek T.R., Smith K.A., et al. Both interleukin 2 and a second T cell-derived factor in EL-4 supernatant have activity as differentiation factors in IgM synthesis. J. Exp. Med. 1984, 160:1605-1621.
218. Nakanishi K., Hirose S., Yoshimoto T., et al. Role and regulation of interleukin (IL)-2 receptor alpha and beta chains in IL-2-driven B-cell growth. Proc. Natl Acad. Sci. USA 1992, 89:3551-3555.
219. Nakarai T., Robertson M.J., Streuli M., et al. Interleukin 2 receptor gamma chain expression on resting and activated lymphoid cells. J. Exp. Med. 1994, 180:241-251.
220. Nelson B.H., Lord J.D., Greenberg P.D. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 1994, 369:333-336.
221. Nelson B.H., McIntosh B.C., Rosencrans L.L., Greenberg P.D. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation. Proc. Natl Acad. Sci. USA 1997, 94:1878-1883.
222. Nevins J.R. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 1998, 9:585-593.
223. Nielsen M., Svejgaard A., Skov S., Odum N. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes. Eur. J. Immunol. 1994, 24:3082-3086.
224. Nikaido T., Shimizu A., Ishida N., et al. Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 1984, 311:631-635.
225. Noguchi M., Yi H., Rosenblatt H.M., et al. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 1993, 73:147-157.
226. Noguchi M., Adelstein S., Cao X., Leonard W.J. Characterization of the human interleukin-2 receptor gamma chain gene. J. Biol. Chem. 1993, 268:13601-13608.
227. Noguchi M., Nakamura Y., Russell S.M., et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993, 262:1877-1880.
228. Noguchi M., Sarin A., Aman M.J., et al. Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain. Proc. Natl Acad. Sci. USA 1997, 94:11534-11539.
229. Nosaka T., van Deursen J.M., Tripp R.A., et al. Defective lymphoid development in mice lacking Jak3. Science 1995, 270:800-802.
230. Ohashi T., Masuda M., Ruscetti S.K. Activation of stat-related DNA-binding factors by erythropoietin and the spleen focus-forming virus. Curr. Top. Microbiol. Immunol. 1996, 211:223-231.
231. Ohbo K., Takasawa N., Ishii N., et al. Functional analysis of the human interleukin 2 receptor gamma chain gene promoter. J. Biol. Chem. 1995, 270:7479-7486.
232. Ohbo K., Suda T., Hashiyama M., et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 1996, 87:956-967.
233. Ortaldo J.R., Mason A.T., Gerard J.P., et al. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immuno-regulatory effects. J. Immunol. 1984, 133:779-783.
234. Otani H., Siegel J.P., Erdos M., et al. Interleukin (IL)-2 and IL-3 induce distinct but overlapping responses in murine IL-3-dependent 32D cells transduced with human IL-2 receptor beta chain: involvement of tyrosine kinase(s) other than p56lck. Proc. Natl Acad. Sci. USA 1992, 89:2789-2793.
235. Otani H., Erdos M., Leonard W.J. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J. Biol. Chem. 1993, 268:22733-22736.
236. Page T.H., Dallman M.J. Molecular cloning of cDNAs for the rat interleukin 2 receptor alpha and beta chain genes: differentially regulated gene activity in response to mitogenic stimulation. Eur. J. Immunol. 1991, 21:2133-2138.
237. Paiardini M., Galati D., Cervasi B., et al. Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals. J. Virol. 2001, 75:10843-11055.
238. Pandey A., Ozaki K., Baumann H., et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 2000, 1:59-64.
239. Parganas E., Wang D., Stravopodis D., et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998, 93:385-395.
240. Park S.Y., Saijo K., Takahashi T., et al. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity 1995, 3:771-782.
241. Pauza C.D. Regulation of human T-lymphocyte gene expression by interleukin 2: immediate-response genes include the proto-oncogene c-myb. Mol. Cell. Biol. 1987, 7:342-348.
242. Pawson T. Protein modules and signalling networks. Nature 1995, 373:573-580.
243. Perkins G.R., Flemming C.L., Kabat D., Collins M.K. The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation. Int. Immunol. 1993, 5:541-549.
244. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat. Genet. 1998, 20:394-397.
245. Puzanov I.J., Bennett M., Kumar V. IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells. J. Immunol. 1996, 157:4282-4285.
246. Queen C., Schneider W.P., Selick H.E., et al. A humanized antibody that binds to the interleukin 2 receptor. Proc. Natl Acad. Sci. USA 1989, 86:10029-10033.
247. Ragheb J.A., Deen M., Schwartz R.H. CD28-mediated regulation of mRNA stability requires sequences within the coding region of the IL-2 mRNA. J. Immunol. 1999, 163:120-129.
248. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 1997, 15:707-747.
249. Rao S., Procko E., Shannon M.F. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 gene. J. Immunol. 2001, 167:4494-4503.
250. Ravichandran K.S., Burakoff S.J. The adapter protein Shc interacts with the interleukin-2 (IL-2) receptor upon IL-2 stimulation. J. Biol. Chem. 1994, 269:1599-1602.
251. Ravichandran K.S., Igras V., Shoelson S.E., et al. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc. Natl Acad. Sci. USA 1996, 93:5275-5280.
252. Reed J.C., Sabath D.E., Hoover R.G., Prystowsky M.B. Recombinant interleukin 2 regulates levels of c-myc mRNA in a cloned murine T lymphocyte. Mol. Cell. Biol. 1985, 5:3361-3368.
253. Reeves R., Spies A.G., Nissen M.S., et al. Molecular cloning of a functional bovine interleukin 2 cDNA. Proc. Natl Acad. Sci. USA 1986, 83:3228-3232.
254. Refaeli Y., Van P.L., London C.A., et al. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998, 8:615-623.
255. Reif K., Burgering B.M., Cantrell D.A. Phosphatidylinositol 3-kinase links the interleukin-2 receptor to protein kinase B and p70 S6 kinase. J. Biol. Chem. 1997, 272:14426-14433.
256. Remillard B., Petrillo R., Maslinski W., et al. Interleukin-2 receptor regulates activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 1991, 266:14167-14170.
257. Ren R., Mayer B.J., Cicchetti P., Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science 1993, 259:1157-1161.
258. Rinkenberger J.L., Wallin J.J., Johnson K.W., Koshland M.E. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 1996, 5:377-386.
259. Robb R.J., Munck A., Smith K.A. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J. Exp. Med. 1981, 154:1455-1474.
260. Robb R.J., Greene W.C., Rusk C.M. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J. Exp. Med. 1984, 160:1126-1146.
261. Rodig S.J., Meraz M.A., White J.M., et al. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 1998, 93:373-383.
262. Roessler E., Grant A., Ju G., et al. Cooperative interactions between the interleukin 2 receptor alpha and beta chains alter the interleukin 2-binding affinity of the receptor subunits. Proc. Natl Acad. Sci. USA 1994, 91:3344-3347.
263. Roman D.G., Toledano M.B., Leonard W.J. Sp1 represses IL-2 receptor alpha chain gene expression. New Biol. 1990, 2:642-647.
264. Rosenberg S.A., Yang J.C., Topalian S.L., et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994, 271:907-913.
265. Rosenberg S.A., Zhai Y., Yang J.C., et al. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp 100 melanoma antigens. J. Natl Cancer Inst. 1998, 90:1894-1900.
266. Ruben S., Poteat H., Tan T.H., et al. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 1988, 241:89-92.
267. Rubin L.A., Nelson D.L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Intern. Med. 1990, 113:619-627.
268. Rudd C.E., Anderson P., Morimoto C., et al. Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation. Immunol. Rev. 1989, 111:225-266.
269. Russell S.M., Keegan A.D., Harada N., et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 1993, 262:1880-1883.
270. Russell S.M., Johnston J.A., Noguchi M., et al. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science 1994, 266:1042-1045.
271. Russell S.M., Tayebi N., Nakajima H., et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 1995, 270:797-800.
272. Sadlack B., Merz H., Schorle H., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
273. Saito Y., Tada H., Sabe H., Honjo T. Biochemical evidence for a third chain of the interleukin-2 receptor. J. Biol. Chem. 1991, 266:22186-22191.
274. Saltzman E.M., Thom R.R., Casnellie J.E. Activation of a tyrosine protein kinase is an early event in the stimulation of T lymphocytes by interleukin-2. J. Biol. Chem. 1988, 263:6956-6959.
275. Saraya K.A., Balkwill F.R. Temporal sequence and cellular origin of interleukin-2 stimulated cytokine gene expression. Br. J. Cancer 1993, 67:514-521.
276. Satoh J., Kim S.U., Kastrukoff L.F. Lymphokine-activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis. J. Neuroimmunol. 1991, 32:111-122.
277. Sauve K., Nachman M., Spence C., et al. Localization in human interleukin 2 of the binding site to the alpha chain (p55) of the interleukin 2 receptor. Proc. Natl Acad. Sci. USA 1991, 88:4636-4640.
278. Sawami H., Terada N., Franklin R.A., et al. Signal transduction by interleukin 2 in human T cells: activation of tyrosine and ribosomal S6 kinases and cell-cycle regulatory genes. J. Cell. Physiol. 1992, 151:367-377.
279. Schindler U., Wu P., Rothe M., et al. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 1995, 2:689-697.
280. Schorle H., Holtschke T., Hunig T., et al. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 1991, 352:621-624.
281. Schreiber S.L., Crabtree G.R. The mechanisms of action of cyclosporin A and FK506. Immunol. Today 1992, 13:136-142.
282. Seigel L.J., Harper M.E., Wong-Staal F, et al. Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. Science 1984, 223:175-178.
283. Seow H.F., Rothel J.S., Radford A.J., Wood P.R. The molecular cloning of ovine interleukin 2 gene by the polymerase chain reaction. Nucleic Acids Res. 1990, 18:7175.
284. Sharfe N., Dadi H.K., Shahar M., Roifman C.M. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl Acad. Sci. USA 1997, 94:3168-3171.
285. Sharon M., Klausner R.D., Cullen B.R., et al. Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science 1986, 234:859-863.
286. Sharon M., Siegel J.P., Tosato G., et al. The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J. Exp. Med. 1988, 167:1265-1270.
287. Sharon M., Gnarra J.R., Leonard W.J. The beta-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells. J. Immunol 1989, 143:2530-2533.
288. Shaw J., Meerovitch K., Bleackley R.C., Paetkau V. Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. J. Immunol. 1988, 140:2243-2248.
289. Shibuya H., Yoneyama M., Nakamura Y., et al. The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment. Nucleic Acids Res. 1990, 18:3697-3703.
290. Shibuya H., Yoneyama M., Ninomiya-Tsuji J., et al. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 1992, 70:57-67.
291. Shibuya H., Kohu K., Yamada K., et al. Functional dissection of p56lck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene. Mol. Cell. Biol. 1994, 14:5812-5819.
292. Siebenlist U., Durand D.B., Bressler P., et al. Promoter region of interleukin-2 gene undergoes chromatin structure changes and confers inducibility on chloramphenicol acetyltransferase gene during activation of T cells. Mol. Cell. Biol. 1986, 6:3042-3049.
293. Siegel J.P., Sharon M., Smith P.L., Leonard W.J. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science 1987, 238:75-78.
294. Skerka C., Decker E.L., Zipfel P.F. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 1995, 270:22500-22506.
295. Smith K.A. The interleukin 2 receptor. Annu. Rev. Cell. Biol. 1989, 5:397-425.
296. Smith K.A. Low-dose daily interleukin-2 immunotherapy: accelerating immune restoration and expanding HIV-specific T-cell immunity without toxicity. AIDS 2001, 15(Suppl. 2):S28-S35.
297. Socolovsky M., Fallon A.E., Wang S., et al. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 1999, 98:181-191.
298. Soudais C., Shiho T., Sharara L.I., et al. Stable and functional lymphoid reconstitution of common cytokine receptor gamma chain deficient mice by retroviral-mediated gene transfer. Blood 2000, 95:3071-3077.
299. Sperisen P., Wang S.M., Soldaini E., et al. Mouse interleukin-2 receptor alpha gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements. J. Biol. Chem. 1995, 270:10743-10753.
300. Sporri B., Kovanen P.E., Sasaki A., et al. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling. Blood 2001, 97:221-226.
301. Sprang S.R., Bazan J.F. Cytokine structural taxonomy and mechanisms of receptor engagement. Cur. Opin. Struct. Biol. 1993, 3:815-827.
302. Straus D.B., Weiss A. The CD3 chains of the T cell antigen receptor associate with the ZAP-70 tyrosine kinase and are tyrosine phosphorylated after receptor stimulation. J. Exp. Med. 1993, 178:1523-1530.
303. Su B., Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 1996, 8:402-411.
304. Su B., Jacinto E., Hibi M., et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 1994, 77:727-736.
305. Sugamura K., Asao H., Kondo M., et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 1996, 14:179-205.
306. Suzuki H., Kundig T.M., Furlonger C., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995, 268:1472-1476.
307. Suzuki J., Takeshita T., Ohbo K., et al. IL-2 receptor subunit, p75: direct demonstration of its IL-2 binding ability by using a novel monoclonal antibody. Int. Immunol. 1989, 1:373-377.
308. Suzuki K., Nakajima H., Saito Y., et al. Janus kinase 3 (Jak3) is essential for common cytokine receptor gamma chain (gamma(c))-dependent signaling: comparative analysis of gamma(c), Jak3, and gamma(c) and Jak3 double-deficient mice. Int. Immunol. 2000, 12:123-132.
309. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996, 4:329-336.
310. Taichman R., Merida I., Torigoe T., et al. Evidence that protein tyrosine kinasse p56-Lck regulates the activity of phosphatidylinositol-3'-kinase in interleukin-2-dependent T-cells. J. Biol. Chem. 1993, 268:20031-20036.
311. Takemoto S., Mulloy J.C., Cereseto A., et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc. Natl Acad. Sci. USA 1997, 94:13897-13902.
312. Takeshita T., Asao H., Suzuki J., Sugamura K. An associated molecule, p64, with high-affinity interleukin 2 receptor. Int. Immunol. 1990, 2:477-480.
313. Takeshita T., Asao H., Ohtani K., et al. Cloning of the gamma chain of the human IL-2 receptor. Science 1992, 257:379-382.
314. Takeshita T., Ohtani K., Asao H., et al. An associated molecule, p64, with IL-2 receptor beta chain. Its possible involvement in the formation of the functional intermediate-affinity IL-2 receptor complex. J. Immunol. 1992, 148:2154-2158.
315. Takeshita T., Arita T., Asao H., et al. Cloning of a novel signal-transducing adaptor molecule containing an SH3 domain and ITAM. Biochem. Biophys. Res. Commun. 1996, 225:1035-1039.
316. Takeshita T., Arita T., Higuchi M., et al. STAM, signal transducing adaptor molecule, is associated with Janus kinases and involved in signaling for cell growth and c-myc induction. Immunity 1997, 6:449-457.
317. Talmadge J.E., Wiltrout R.H., Counts D.F., et al. Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes. Cell. Immunol. 1986, 102:261-272.
318. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 1995, 268:251-255.
319. Taniguchi T., Matsui H., Fujita T., et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature 1983, 302:305-310.
320. Teglund S., McKay C., Schuetz E., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 1998, 93:841-850.
321. Teshigawara K., Wang H.M., Kato K., Smith K.A. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins. J. Exp. Med. 1987, 165:223-238.
322. Thomis D.C., Gurniak C.B., Tivol E., et al. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3. Science 1995, 270:794-797.
323. Thompson C.B., Lindsten T., Ledbetter J.A., et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl Acad. Sci. USA 1989, 86:1333-1337.
324. Tocci M.J., Matkovich D.A., Collier K.A., et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 1989, 143:718-726.
325. Toledano M.B., Roman D.G., Halden N.F., et al. The same target sequences are differentially important for activation of the interleukin 2 receptor alpha-chain gene in two distinct T-cell lines. Proc. Natl Acad. Sci. USA 1990, 87:1830-1834.
326. Torigoe T., Saragovi H.U., Reed J.C. Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line. Proc. Natl Acad. Sci. USA 1992, 89:2674-2678.
327. Trinchieri G., Matsumoto-Kobayashi M., Clark S.C., et al. Response of resting human peripheral blood natural killer cells to interleukin 2. J. Exp. Med. 1984, 160:1147-1169.
328. Truitt K.E., Mills G.B., Turck C.W., Imboden J.B. SH2-dependent association of phosphatidylinositol 3'-kinase 85-kDa regulatory subunit with the interleukin-2 receptor beta chain. J. Biol. Chem. 1994, 269:5937-5943.
329. Tsudo M., Uchiyama T., Uchino H. Expression of Tac antigen on activated normal human B cells. J. Exp. Med. 1984, 160:612-617.
330. Tsudo M., Kozak R.W., Goldman C.K., Waldmann T.A. Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex. Proc. Natl Acad. Sci. USA 1986, 83:9694-9698.
331. Tsudo M., Goldman C.K., Bongiovanni K.F., et al. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these. Proc. Natl Acad. Sci. USA 1987, 84:5394-5398.
332. Tsudo M., Karasuyama H., Kitamura F., et al. Reconstitution of a functional IL-2 receptor by the betachain cDNA. A newly acquired receptor transduces negative signal. J. Immunol. 1989, 143:4039-4043.
333. Tsudo M., Karasuyama H., Kitamura F., et al. The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms. J. Immunol. 1990, 145:599-606.
334. Turner B., Rapp U., App H., et al. Interleukin 2 induces tyrosine phosphorylation and activation of p72-74 Raf-1 kinase in a T-cell line. Proc. Natl Acad. Sci. USA 1991, 88:1227-1231.
335. Turner M., Mee P.J., Costello P.S., et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 1995, 378:298-302.
336. Uchiyama T., Broder S., Waldmann T.A. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J. Immunol. 1981, 126:1393-1397.
337. Udy G.B., Towers R.P., Snell R.G., et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl Acad. Sci. USA 1997, 94:7239-7244.
338. Umlauf S.W., Beverly B., Lantz O., Schwartz R.H. Regulation of interleukin 2 gene expression by CD28 costimulation in mouse T-cell clones: both nuclear and cytoplasmic RNAs are regulated with complex kinetics. Mol. Cell. Biol. 1995, 15:3197-3205.
339. Van Parijs L., Refaeli Y., Lord J.D., et al. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 1999, 11:281-288.
340. Vanhecke D., Leclercq G., Plum J., Vandekerckhove B. Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J. Immunol. 1995, 155:1862-1872.
341. Veillette A., Bookman M.A., Horak E.M., et al. Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck. Nature 1989, 338:257-259.
342. Waldmann T.A., Goldman C.K., Robb R.J., et al. Expression of interleukin 2 receptors on activated human B cells. J. Exp. Med. 1984, 160:1450-1466.
343. Waldmann T.A. The multi-subunit interleukin-2 receptor. Annu. Rev. Biochem. 1989, 58:875-911.
344. Waldmann T.A., O'Shea J. The use of antibodies against the IL-2 receptor in transplantation. Curr. Opin. Immunol. 1998, 10:507-512.
345. Waldmann T.A., Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu. Rev. Immunol. 1999, 17:19-49.
346. Waldmann T.A., Dubois S., Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001, 14:105-110.
347. Walker E., Leemhuis T., Roeder W. Murine B lymphoma cell lines release functionally active interleukin 2 after stimulation with Staphylococcus aureus. J. Immunol. 1988, 140:859-865.
348. Wang A., Lu S.D., Mark D.F. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 1984, 224:1431-1433.
349. Wang H.M., Smith K.A. The interleukin 2 receptor. Functional consequences of its bimolecular structure. J. Exp. Med. 1987, 166:1055-1069.
350. Wang H.Y., Paul W.E., Keegan A.D. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 1996, 4:113-121.
351. Wange R.L., Kong A.N., Samelson L.E. A tyrosine-phosphorylated 70-kDa protein binds a photoaffinity analogue of ATP and associates with both the zeta chain and CD3 components of the activated T cell antigen receptor. J. Biol. Chem. 1992, 267:11685-11688.
352. Ward S.G., Cantrell D.A. Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 2001, 13:332-338.
353. Webb G.C., Campbell H.D., Lee J.S., Young I.G. Mapping the gene for murine T-cell growth factor, Il-2, to bands B-C on chromosome 3 and for the alpha chain of the IL2-receptor, Il-2ra, to bands A2-A3 on chromosome 2. Cytogenet. Cell. Genet. 1990, 54:164-168.
354. Weigel U., Meyer M., Sebald W. Mutant proteins of human interleukin 2. Renaturation yield, proliferative activity and receptor binding. Eur. J. Biochem. 1989, 180:295-300.
355. Welham M.J., Duronio V., Leslie K.B., et al. Multiple hemopoietins, with the exception of interleukin-4, induce modification of Shc and mSos1, but not their translocation. J. Biol. Chem. 1994, 269:21165-21176.
356. Whitwam T., Haskins M.E., Henthorn P.S., et al. Retroviral marking of canine bone marrow: long-term, high-level expression of human interleukin-2 receptor common gamma chain in canine lymphocytes. Blood 1998, 92:1565-1575.
357. Willerforld D.M., Chen J., Ferry J.A., et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
358. Witthuhn B.A., Silvennoinen O., Miura O., et al. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 1994, 370:153-157.
359. Xue H.-H., Kovanen P.E., Pise-Masison C.A., et al. IL-2 negatively regulates IL-7 receptor α chain expression in activated T lymphocytes. Proc. Natl Acad. Sci. USA 2002, 99:13759-13764.
360. Yamada M., Takeshita T., Miura S., et al. Loss of hippocampal CA3 pyramidal neurons in mice lacking STAM1. Mol. Cell. Biol. 2001, 21:3807-3819.
361. Yeh J.H., Lecine P., Nunes J.A., et al. Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus. Mol. Cell. Biol. 2001, 21:4515-4527.
362. Yokota T., Arai N., Lee F., et al. Use of a cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: expression of T-cell growth-factor activity after transfection of monkey cells. Proc. Natl Acad. Sci. USA 1985, 82:68-72.
363. Yoshimura A., Ohkubo T., Kiguchi T., et al. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 1995, 14:2816-2826.
364. Yoshimura A., Ichihara M., Kinjyo I., et al. Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J. 1996, 15:1055-1063.
365. Yu C.L., Meyer D.J., Campbell G.S., et al. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 1995, 269:81-83.
366. Yu C.L., Jin Y.J., Burakoff S.J. Cytosolic tyrosine dephosphorylation of STAT5. Potential role of SHP-2 in STAT5 regulation. J. Biol. Chem. 2000, 275:599-604.
367. Yu C.R., Lin J.X., Fink D.W., et al. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J. Immunol. 1996, 157:126-137.
368. Zhu M.H., Berry J.A., Russell S.M., Leonard W.J. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta. J. Biol. Chem. 1998, 273:10719-10725.
369. Zhu X., Suen K.L., Barbacid M., et al. Interleukin-2-induced tyrosine phosphorylation of Shc proteins correlates with factor-dependent T cell proliferation. J. Biol. Chem. 1994, 269:5518-5522.
370. Zubler R.H., Lowenthal J.W., Erard F., et al. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J. Exp. Med. 1984, 160:1170-1183.
371. Zurawski S.M., Zurawski G. Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding. EMBO J. 1989, 8:2583-2590.
372. Zurawski S.M., Imler J.L., Zurawski G. Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction. EMBO J. 1990, 9:3899-3905.
373. Zvelebil M.J., MacDougall L., Leevers S., et al. Structural and functional diversity of phosphoinositide 3-kinases. Phil. Trans. R Soc. Lond. B Biol. Sci. 1996, 351:217-223.